We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ITOS market cap is 257.56M. The company's latest EPS is USD -3.0832 and P/E is -2.28.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 35M | 0 |
| Operating Income | -43.28M | -40.15M | -47.23M | -14.17M | -48.8M |
| Net Income | -32.24M | -30.55M | -38.22M | -7.13M | -45.36M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 344.78M | 267.63M | 12.6M |
| Operating Income | -28.05M | -45.24M | 244.9M | 126.32M | -151.1M |
| Net Income | -26.54M | -43.4M | 214.52M | 96.65M | -112.64M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 677.64M | 667.59M | 629.77M | 751.84M | 723.08M |
| Total Liabilities | 79.38M | 92.36M | 88.57M | 87.97M | 91.39M |
| Total Equity | 598.26M | 575.23M | 541.2M | 663.87M | 631.69M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 30.74M | 344.56M | 884.71M | 754.99M | 667.59M |
| Total Liabilities | 15.08M | 21.36M | 331.89M | 91.66M | 92.36M |
| Total Equity | -36.09M | 323.2M | 552.82M | 663.33M | 575.23M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -85.09M | -103.76M | -32.4M | -66.33M | -103.68M |
| Investing | 11.1M | 72.66M | -69.6M | -53.28M | -144.77M |
| Financing | 806k | 1.11M | 22k | 122.4M | 121.96M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -23.15M | -25.18M | 513.14M | -111.19M | -103.76M |
| Investing | -926k | -377k | -1.24M | -446.06M | 72.66M |
| Financing | 22.54M | 340.34M | 3.66M | 1.98M | 1.11M |
| Market Cap | 257.56M |
| Price to Earnings Ratio | -2.28 |
| Price to Sales Ratio | 20.42 |
| Price to Cash Ratio | 1.02 |
| Price to Book Ratio | 0.45 |
| Dividend Yield | - |
| Shares Outstanding | 36.53M |
| Average Volume (1 week) | 445.82k |
| Average Volume (1 Month) | 300.14k |
| 52 Week Change | -40.66% |
| 52 Week High | 18.75 |
| 52 Week Low | 6.67 |
| Spread (Intraday) | 0.42 (5.86%) |
| Company Name | iTeos Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.iteostherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
